These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 34444750)
21. Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin. Abbasi F; Carantoni M; Chen YD; Reaven GM Diabetes Care; 1998 Aug; 21(8):1301-5. PubMed ID: 9702437 [TBL] [Abstract][Full Text] [Related]
22. Results of a placebo-controlled study of the metabolic effects of the addition of metformin to sulfonylurea-treated patients. Evidence for a central role of adipose tissue. Abbasi F; Kamath V; Rizvi AA; Carantoni M; Chen YD; Reaven GM Diabetes Care; 1997 Dec; 20(12):1863-9. PubMed ID: 9405908 [TBL] [Abstract][Full Text] [Related]
23. Sustained reduction in plasma free fatty acid concentration improves insulin action without altering plasma adipocytokine levels in subjects with strong family history of type 2 diabetes. Bajaj M; Suraamornkul S; Kashyap S; Cusi K; Mandarino L; DeFronzo RA J Clin Endocrinol Metab; 2004 Sep; 89(9):4649-55. PubMed ID: 15356076 [TBL] [Abstract][Full Text] [Related]
24. Free fatty acids and type 2 diabetes mellitus. Wyne KL Am J Med; 2003 Dec; 115 Suppl 8A():29S-36S. PubMed ID: 14678863 [TBL] [Abstract][Full Text] [Related]
25. Dual regulation of adipose triglyceride lipase by pigment epithelium-derived factor: a novel mechanistic insight into progressive obesity. Dai Z; Qi W; Li C; Lu J; Mao Y; Yao Y; Li L; Zhang T; Hong H; Li S; Zhou T; Yang Z; Yang X; Gao G; Cai W Mol Cell Endocrinol; 2013 Sep; 377(1-2):123-34. PubMed ID: 23850519 [TBL] [Abstract][Full Text] [Related]
26. [Profile of free fatty acids (FFA) in serum of young Colombians with obesity and metabolic syndrome]. Bermudez JA; Velásquez CM Arch Latinoam Nutr; 2014 Dec; 64(4):248-57. PubMed ID: 26336720 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of adipose tissue lipolysis increases intramuscular lipid and glycogen use in vivo in humans. van Loon LJ; Thomason-Hughes M; Constantin-Teodosiu D; Koopman R; Greenhaff PL; Hardie DG; Keizer HA; Saris WH; Wagenmakers AJ Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E482-93. PubMed ID: 15886227 [TBL] [Abstract][Full Text] [Related]
28. Effects of fatty acids and ketone bodies on basal insulin secretion in type 2 diabetes. Boden G; Chen X Diabetes; 1999 Mar; 48(3):577-83. PubMed ID: 10078559 [TBL] [Abstract][Full Text] [Related]
30. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. Groop LC; Saloranta C; Shank M; Bonadonna RC; Ferrannini E; DeFronzo RA J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032 [TBL] [Abstract][Full Text] [Related]
31. Additive hypoglycemic effects of drugs that modify free-fatty acid metabolism by different mechanisms in rats with streptozocin-induced diabetes. Reaven GM; Chang H; Hoffman BB Diabetes; 1988 Jan; 37(1):28-32. PubMed ID: 3275556 [TBL] [Abstract][Full Text] [Related]
32. Thiazolidinediones increase plasma-adipose tissue FFA exchange capacity and enhance insulin-mediated control of systemic FFA availability. Oakes ND; Thalén PG; Jacinto SM; Ljung B Diabetes; 2001 May; 50(5):1158-65. PubMed ID: 11334421 [TBL] [Abstract][Full Text] [Related]
33. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Muzurović E; Mikhailidis DP; Mantzoros C Metabolism; 2021 Jun; 119():154770. PubMed ID: 33864798 [TBL] [Abstract][Full Text] [Related]
34. Free fatty acids, insulin resistance, and type 2 diabetes mellitus. Boden G Proc Assoc Am Physicians; 1999; 111(3):241-8. PubMed ID: 10354364 [TBL] [Abstract][Full Text] [Related]
35. Suppression of plasma free fatty acids reduces myocardial lipid content and systolic function in type 2 diabetes. Wolf P; Winhofer Y; Krssak M; Smajis S; Harreiter J; Kosi-Trebotic L; Fürnsinn C; Anderwald CH; Baumgartner-Parzer S; Trattnig S; Luger A; Krebs M Nutr Metab Cardiovasc Dis; 2016 May; 26(5):387-92. PubMed ID: 27118107 [TBL] [Abstract][Full Text] [Related]
37. The effects of exercise and adipose tissue lipolysis on plasma adiponectin concentration and adiponectin receptor expression in human skeletal muscle. Punyadeera C; Zorenc AH; Koopman R; McAinch AJ; Smit E; Manders R; Keizer HA; Cameron-Smith D; van Loon LJ Eur J Endocrinol; 2005 Mar; 152(3):427-36. PubMed ID: 15757860 [TBL] [Abstract][Full Text] [Related]
38. Youth with type 2 diabetes have hepatic, peripheral, and adipose insulin resistance. Cree-Green M; Wiromrat P; Stuppy JJ; Thurston J; Bergman BC; Baumgartner AD; Bacon S; Scherzinger A; Pyle L; Nadeau KJ Am J Physiol Endocrinol Metab; 2019 Feb; 316(2):E186-E195. PubMed ID: 30562061 [TBL] [Abstract][Full Text] [Related]
39. Role of insulin resistance and lipotoxicity in non-alcoholic steatohepatitis. Cusi K Clin Liver Dis; 2009 Nov; 13(4):545-63. PubMed ID: 19818304 [TBL] [Abstract][Full Text] [Related]
40. Modeling of free fatty acid dynamics: insulin and nicotinic acid resistance under acute and chronic treatments. Andersson R; Kroon T; Almquist J; Jirstrand M; Oakes ND; Evans ND; Chappel MJ; Gabrielsson J J Pharmacokinet Pharmacodyn; 2017 Jun; 44(3):203-222. PubMed ID: 28224315 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]